PRAVASTATIN SODIUM
- Product NDC
- 0781-5231
- 11-digit product format
- 007815231
- Labeler code
- 0781
- Product ID
- 0781-5231_56c39347-1ea1-4306-bd14-dda785df7143
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PRAVASTATIN SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Sandoz Inc
- Application
- ANDA076397
- Marketing category
- ANDA
- Marketing start
- 2014-04-28
- Marketing end
- 0000-00-00
- Substance
- PRAVASTATIN SODIUM
- Active strength
- 10 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0781-5231-01 | 2021-06-18 | C162847 | 48780-1 | 9d75b9d0-9a5d-f424-e053-dadaa90a57ce | 52dc677e-98a9-4c2b-8e00-27c5d660179b |
| 0781-5231-10 | 2021-06-18 | C162847 | 48780-1 | 9d75b9d0-9a5d-f424-e053-dadaa90a57ce | 52dc677e-98a9-4c2b-8e00-27c5d660179b |
| 0781-5231-92 | 2021-06-18 | C162847 | 48780-1 | 9d75b9d0-9a5d-f424-e053-dadaa90a57ce | 52dc677e-98a9-4c2b-8e00-27c5d660179b |
| 0781-5231-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9a5d-f424-e053-dadaa90a57ce | 52dc677e-98a9-4c2b-8e00-27c5d660179b |
| 0781-5231-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9a5d-f424-e053-dadaa90a57ce | 52dc677e-98a9-4c2b-8e00-27c5d660179b |
| 0781-5231-92 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9a5d-f424-e053-dadaa90a57ce | 52dc677e-98a9-4c2b-8e00-27c5d660179b |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-5231-10 | EA - Each | 0781-5231 | 276553ab-6722-4cae-aa94-131374ad5f0f | 1 | 2022-06-06 |
| 0781-5231-92 | EA - Each | 0781-5231 | c5f212ba-eb19-4c5e-ae14-865fa762c54c | 1 | 2014-04-03 |